Women suffer more severe symptoms of rheumatoid arthritis than men, a recent study revealed.Natiki Shuron was diagnosed with rheumatoid arthritis about 10 years ago."When I first started, ...

One way to prepare for these conversations is for adults with moderate to severe RA to assess how they are feeling on a day-to-day basis, what they’re able to do — or not — and their symptoms.

Rheumatoid arthritis (RA) is a type of inflammatory arthritis that primarily affects the joints of the hands, wrists, and knees, but any joint in the body can be affected. Beyond early-stage ...

Learn about the various types of rheumatoid arthritis and conditions commonly mistaken for RA, ... people with seronegative RA often have more severe RA symptoms when they first go to see a doctor.

Rheumatoid arthritis is a disease that mostly affects the joints. If left untreated, it can go from bad to worse. Read on to find out all about the signs of progression and what you can do about them.

To keep your moderate to severe RA from getting worse and ease your symptoms, your doctor will try a series of treatments, from NSAIDs to surgery, to find the best one for you.

RA primarily affects the joints, but it can also cause symptoms in other areas of the body, such as the skin. Learn how RA can cause rashes, nodules, and other skin problems.

Medically reviewed by Geetika Gupta, MD People with rheumatoid arthritis (RA) are at a higher risk for infections, including COVID-19. ... along with severe symptoms and complications.

Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects individuals across all ages and genders.

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis through 52 weeks, according to phase 3 trial results published in Annals ...

Since the 1970s, rheumatologists have increasingly reported seeing patients with milder onset of rheumatoid arthritis and a less-severe disease course than in preceding decades. Are these ...

Ivarmacitinib, a novel Janus kinase 1 inhibitor, may be considered a potential treatment for patients with moderate to severe active rheumatoid arthritis who have an inadequate response to csDMARDs.